Page last updated: 2024-11-03

propidium and ER-Negative PR-Negative HER2-Negative Breast Cancer

propidium has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Propidium: Quaternary ammonium analog of ethidium; an intercalating dye with a specific affinity to certain forms of DNA and, used as diiodide, to separate them in density gradients; also forms fluorescent complexes with cholinesterase which it inhibits.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Liu, XD1
Song, CY1
Kong, CC1
Tian, X1

Other Studies

1 other study available for propidium and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Bufalin Induces Programmed Necroptosis in Triple-Negative Breast Cancer Drug-Resistant Cell Lines through RIP1/ROS-Mediated Pathway.
    Chinese journal of integrative medicine, 2022, Volume: 28, Issue:10

    Topics: Antioxidants; Apoptosis; Bufanolides; Caspase 3; Cell Line; Cell Line, Tumor; Cysteine; Docetaxel; D

2022